ARGOS THERAPEUTICS INC 4
4 · ARGOS THERAPEUTICS INC · Filed Jan 23, 2017
Insider Transaction Report
Form 4
Nicolette Charles A.
CSO and Vice President of R&D
Transactions
- Award
Common Stock
2017-01-19+16,753→ 92,796 total - Award
Stock Option (right to buy)
[F1]2017-01-19+185,000→ 185,000 totalExercise: $4.85Exp: 2027-01-18→ Common Stock (185,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 19, 2017 and vests as to 25% of the shares underlying this option on January 1, 2018, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning January 1, 2018.
Signature
/s/ Lori R. Harrelson, attorney-in-fact|2017-01-20